Roanoke Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,068
Closed -$205K 104
2015
Q4
$205K Sell
4,068
-14,803
-78% -$746K 0.09% 98
2015
Q3
$889K Hold
18,871
0.33% 66
2015
Q2
$1.02M Hold
18,871
0.33% 67
2015
Q1
$1.03M Sell
18,871
-360
-2% -$20.4K 0.34% 66
2014
Q4
$1.04M Buy
19,231
+14,803
+334% +$825K 0.36% 67
2014
Q3
$250K Buy
4,428
+262
+6% +$14.7K 0.1% 98
2014
Q2
$230K Sell
4,166
-262
-6% -$14.3K 0.09% 101
2014
Q1
$240K Sell
4,428
-84
-2% -$4.35K 0.11% 95
2013
Q4
$215K Hold
4,512
0.1% 98
2013
Q3
$204K Buy
+4,512
New +$206K 0.1% 97

Other funds holding MRK

Roanoke Asset Management's MRK Position: Q1 2016 in Review

Roanoke Asset Management sold out of Merck (MRK) in Q1 2016, closing a stake of 4,068 shares — an estimated $205K sold.

Roanoke Asset Management first reported a position in MRK in Q3 2013 and held it in 10 quarters. The position peaked at $1.04M in Q4 2014. 1,744 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Roanoke Asset Management reported no remaining Merck position as of Q1 2016 after selling out during the quarter.
  • Roanoke Asset Management sold 4,068 Merck shares in Q1 2016, an estimated $205K.
  • Roanoke Asset Management first reported a position in Merck in Q3 2013 and held it in 10 quarters.
  • Roanoke Asset Management's Merck position peaked at $1.04M in Q4 2014.
  • 1,744 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Roanoke Asset Management's 13F filing for Q1 2016, filed 28 Apr 2016.